+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunoglobulins in sera of patients with porphyria cutanea tarda



Immunoglobulins in sera of patients with porphyria cutanea tarda



Acta Hepato-Gastroenterologica 25(1): 20-22



Serum immunoglobulins (IgG, IgA and IgM) were measured in 67 patients with porphyria cutanea tarda and liver dysfunction. Immunoglobulins, especially IgG and IgM, were significantly decreased.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040361652

Download citation: RISBibTeXText

PMID: 636736


Related references

Mechanism of blister formation in porphyria cutanea tarda. I. Histopathological observation of blisters in three cases of porphyria cutanea tarda. Journal of Dermatology 14(6): 551-555, 1987

Mechanism of bullous formation in porphyria cutanea tarda. 1. Histopathological observation of bullae in 3 cases of porphyria cutanea tarda. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 97(4): 471-477, 1987

Immunoglobulins IgG, IgA, IgM, IgD and IgE in porphyria cutanea tarda. Dermatologische Monatschrift 161(5): 370-373, 1975

Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria. Enzyme 16(1): 354-366, 1973

The use of Carbolen in the treatment of porphyria cutanea tarda. In relation to the article by B.S. Pankov: "Carbolen in the treatment of porphyria cutanea tarda" (Vestnik dermatologii i venerologii, No 4, 1967). Vestnik Dermatologii i Venerologii 43(5): 63-66, 1969

Symptomatic porphyria. II. Localization of serum substances in the skin of patients with porphyria cutanea tarda (PCT). South African Medical Journal 1971: 57-58, 1971

Urinary porphyrinogens in normal subjects and in patients with porphyria cutanea tarda and acute intermittent porphyria. Hormone and Metabolic Research 25(8): 454-455, 1993

Increased risk of hepatocellular cancer in patients with porphyria acuta intermittens or porphyria cutanea tarda. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 1291, 1986

Serum vitamin E, cholesterol and triglyceride concentrations in patients with acute hepatic porphyria and porphyria cutanea tarda. Polski Tygodnik Lekarski 39(3): 87-89, 1984

Activity of delta-aminolaevulinic acid (ALAD) in erythrocytes of patients with chronic hepatic porphyria (porphyria cutanea tarda). Polskie Archiwum Medycyny Wewnetrznej 89(3): 212-216, 1993

Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene. Archives of Dermatology 146(11): 1313-1314, 2010

Depletion of histidine and tryptophan serum levels in porphyria cutanea tarda and congenital erythropoietic porphyria patients after irradiation with visible light. Photo-Dermatology 3(2): 92-97, 1986

Serum enzyme activities in hepatic porphyria. A comparison of the changes in porphyria cutanea tarda and in experimental porphyria of the rat. Klinische Wochenschrift 45(11): 587-588, 1967

Dual porphyria coexistence of porphyria cutanea tarda and acute intermittent porphyria in the same members of a family. Revista Argentina de Dermatologia 69(3): 196-201, 1988

New form of dual porphyria coexistent acute intermittent porphyria and porphyria cutanea tarda. European Journal of Clinical Investigation 19(1): 20-25, 1989